Trophic serves as a strategic partner for all aspects of communications for life science companies. We apply a deep understanding of both the science and business of drug development and the capital needed for success. Based on breadth and depth of experience, Trophic has become the go-to advisory for presenting corporate stories and scientific concepts. Current client portfolio ranges from biotech start-ups, listed biopharmas and small and large pharmaceutical companies.

TROPHIC TWITTER FEED

Follow us on Twitter to stay tuned on biotech news and the inner workings of the Trophic team

Recent publication from @UW researchers shows that combined blockade of #CXCL12, the #NOXA12 target, signaling through CXCR4 and PD-1 can reactivate tumor-specific T cells in the tumor microenvironment of human #pancreascancer: https://t.co/Q4bg7AltLD

Happy #birthday, alles Gute, and tanti auguri to our favorite #officedog, Bean!

August’s #BeanoftheMonth is here to remind you that happiness, much like that induced by rolling around in a field of flowers, is key to #business success. This
@StanfordGSB article illustrates 4 principles to creating a #happy #officeenvironment: https://t.co/m1Bno1jfpo

Load More...